ArticleBMC surgery2026
Clinical efficacy of intervertebral foraminoscopic debridement with catheter drainage for lumbar spinal epidural abscess.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the clinical efficacy of percutaneous transforaminal endoscopic debridement with catheter drainage for the treatment of single-segment lumbar spinal epidural abscess (SEA).
methodsWe retrospectively analysed clinical data from 12 patients with nonspecific single-segment spinal epidural abscess who underwent percutaneous transforaminal endoscopy at our hospital between March 2019 and June 2023. Intraoperative lesion tissue was subjected to microbial culture and histopathological examination. Postoperative anti-infection treatment was given based on drug sensitivity and clinical response. Postoperative CT/MRI was performed to evaluate abscess clearance. WBC, CRP, and ESR levels were measured before and after surgery, and the degree of symptom relief was evaluated using the VAS, ODI, and MacNab criteria. Dynamic radiographs were obtained to evaluate spinal stability, and imaging data were reviewed to assess infection recurrence.
resultsAll patients successfully underwent surgery without postoperative complications. Various indicators improved significantly at 1 week, 1 month, and 3 months after surgery, as well as at the last follow-up, compared with preoperative levels (P < 0.05). Clinical symptoms improved significantly. According to MacNab criteria, the excellent and good rate was 91.7%. Two patients (16.7%) underwent lumbar fusion surgery due to new neurological symptoms in both legs after 3 months. In the remaining patients, infectious symptoms improved, and no recurrence occurred during the follow-up period.
conclusionsPercutaneous transforaminal endoscopic debridement with catheter drainage is a valuable and minimally invasive surgical approach for the treatment of SEA with preliminary feasibility and safety under certain conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.